ES2043012T3 - Derivados de carboxamidas aromaticas y heterociclicas como agentes antineoplasticos. - Google Patents

Derivados de carboxamidas aromaticas y heterociclicas como agentes antineoplasticos.

Info

Publication number
ES2043012T3
ES2043012T3 ES89305141T ES89305141T ES2043012T3 ES 2043012 T3 ES2043012 T3 ES 2043012T3 ES 89305141 T ES89305141 T ES 89305141T ES 89305141 T ES89305141 T ES 89305141T ES 2043012 T3 ES2043012 T3 ES 2043012T3
Authority
ES
Spain
Prior art keywords
derivatives
heterociclic
carboxamides
aromatic
antineoplastic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89305141T
Other languages
English (en)
Spanish (es)
Inventor
Anton Franz Josef Fliri
Rodney Caughren Schnur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2043012T3 publication Critical patent/ES2043012T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Graft Or Block Polymers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES89305141T 1988-05-24 1989-05-22 Derivados de carboxamidas aromaticas y heterociclicas como agentes antineoplasticos. Expired - Lifetime ES2043012T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19803488A 1988-05-24 1988-05-24

Publications (1)

Publication Number Publication Date
ES2043012T3 true ES2043012T3 (es) 1993-12-16

Family

ID=22731735

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89305141T Expired - Lifetime ES2043012T3 (es) 1988-05-24 1989-05-22 Derivados de carboxamidas aromaticas y heterociclicas como agentes antineoplasticos.

Country Status (25)

Country Link
EP (1) EP0343893B1 (en:Method)
JP (1) JPH0678331B2 (en:Method)
KR (1) KR910006864B1 (en:Method)
CN (1) CN1023700C (en:Method)
AT (1) ATE79114T1 (en:Method)
AU (1) AU601905B2 (en:Method)
CA (1) CA1328871C (en:Method)
DD (1) DD283815A5 (en:Method)
DE (1) DE68902358T2 (en:Method)
DK (1) DK249389A (en:Method)
ES (1) ES2043012T3 (en:Method)
FI (1) FI892498A7 (en:Method)
GR (1) GR3005844T3 (en:Method)
HU (1) HU202507B (en:Method)
IE (1) IE891667L (en:Method)
IL (1) IL90337A0 (en:Method)
MX (1) MX173140B (en:Method)
MY (1) MY106035A (en:Method)
NO (1) NO172389C (en:Method)
NZ (1) NZ229234A (en:Method)
PL (1) PL154875B1 (en:Method)
PT (1) PT90622B (en:Method)
SU (1) SU1681728A3 (en:Method)
YU (1) YU47019B (en:Method)
ZA (1) ZA893862B (en:Method)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2790299B2 (ja) * 1989-02-01 1998-08-27 保土谷化学工業株式会社 ペンゾチアゾール誘導体
US5262400A (en) * 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
RU2196769C2 (ru) * 1995-08-30 2003-01-20 Джи. Ди. Сирл Энд Ко. Производные аминобензойной кислоты, фармацевтическая композиция
US5716281A (en) * 1995-11-27 1998-02-10 Sega Enterprises, Ltd. Game apparatus using a vehicle with an optical image synthesizing system
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
PL340727A1 (en) 1997-11-10 2001-02-26 Bristol Myers Squibb Co Benzothiazolic inhibitors of proteinous thyrosinic kinase
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
AU3406599A (en) * 1998-04-09 1999-11-01 Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin Novel benzyl guanidine derivatives for therapy and (in-vivo) and (in-vitro) diagnosis
ATE385794T1 (de) 2000-06-21 2008-03-15 Hoffmann La Roche Benzothiazolderivate zur behandlung von alzheimer und parkinson
US6620811B2 (en) * 2001-11-19 2003-09-16 Hoffmann-La Roche Inc. Isonicotin- and nicotinamide derivatives of benzothiazoles
US6599901B1 (en) * 2001-11-19 2003-07-29 Hoffman-La Roche Inc. Pyridone substituted benzothiazole derivatives
US6624163B2 (en) 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
GB0130868D0 (en) 2001-12-24 2002-02-06 Univ Strathclyde New compounds
CN100357283C (zh) * 2002-04-02 2007-12-26 中国科学院上海药物研究所 一类甲硫氨酰氨肽酶抑制剂
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
ATE407133T1 (de) * 2003-05-13 2008-09-15 Hoffmann La Roche 2-imidazo-benzothiazole als adenosin-rezeptor liganden
BRPI0410440A (pt) * 2003-05-19 2006-06-06 Hoffmann La Roche derivados de benzotiazol como ligandos de receptor de adenosina
KR100765565B1 (ko) * 2003-05-21 2007-10-09 에프. 호프만-라 로슈 아게 벤조티아졸 유도체 및 그의 아데노신 에이2에이 수용체에관련된 질병의 치료에서의 용도
PL1633355T3 (pl) * 2003-05-30 2008-10-31 Hoffmann La Roche Pochodne benzotiazolu i ich zastosowanie w leczeniu chorób związanych z receptorem adenozynowym A2A
JP4726238B2 (ja) * 2003-07-28 2011-07-20 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ベンズイミダゾール、ベンズチアゾールおよびベンゾキサゾール誘導体およびｌｔａ４ｈモジュレーターとしてのそれらの使用
EA011279B1 (ru) 2004-05-24 2009-02-27 Ф. Хоффманн-Ля Рош Аг (4-метокси-7-морфолин-4-илбензотиазол-2-ил)-амид 4-гидрокси-4-метилпиперидин-1-карбоновой кислоты
CN1989139B (zh) * 2004-07-22 2010-05-12 弗·哈夫曼-拉罗切有限公司 苯并噻唑衍生物
CN1989117B (zh) * 2004-07-22 2011-01-19 弗·哈夫曼-拉罗切有限公司 取代的苯并噻唑
ES2309814T3 (es) 2004-11-05 2008-12-16 F. Hoffmann-La Roche Ag Proceso para la obtencion de derivados del acido isonicotinico.
PL1863818T3 (pl) 2005-03-23 2010-08-31 Hoffmann La Roche Pochodne acetylenylo-pirazolo-pirymidyny jako antagoniści MGLUR2
JP5048675B2 (ja) 2005-09-27 2012-10-17 エフ．ホフマン−ラ ロシュ アーゲー ｍＧｌｕＲ２アンタゴニストとしてのオキサジアゾリルピラゾロ−ピリミジン類
EP1994017A2 (en) * 2006-03-15 2008-11-26 4Sc Ag Novel heterocyclic nf-kb inhibitors
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
EP2311842A3 (en) * 2008-06-24 2011-07-13 Takeda Pharmaceutical Company Limited PI3K/M TOR inhibitors
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
WO2013049407A2 (en) * 2011-09-30 2013-04-04 Kineta, Inc Anti-viral compounds
KR101996343B1 (ko) 2012-01-27 2019-07-05 고쿠리츠 다이가쿠 호진 교토 다이가쿠 전능성 줄기세포의 심근분화 유도방법
US10196609B2 (en) 2013-03-08 2019-02-05 Kyoto University Composition for promoting cardiac differentiation of pluripotent stem cell comprising EGFR inhibitor
EP3045451B1 (en) * 2013-09-13 2018-03-28 Kyoto University Compound promoting differentiation of pluripotent stem cells into cardiomyocytes
US10233426B2 (en) 2014-05-30 2019-03-19 Kyoto University Method for inducing cardiac differentiation of pluripotent stem cell with low-molecular compounds
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN110590735B (zh) * 2019-09-30 2021-07-23 江苏国泰超威新材料有限公司 一种环状硫酸酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61225168A (ja) * 1985-03-30 1986-10-06 Nippon Tokushu Noyaku Seizo Kk 新規ベンズアミド、その製法及び殺虫剤
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
GB8611606D0 (en) * 1986-05-13 1986-06-18 Fbc Ltd Fungicides

Also Published As

Publication number Publication date
SU1681728A3 (ru) 1991-09-30
NO892059L (no) 1989-11-27
DE68902358D1 (de) 1992-09-10
DK249389A (da) 1989-11-27
PT90622B (pt) 1994-10-31
JPH0217181A (ja) 1990-01-22
KR890017248A (ko) 1989-12-15
DD283815A5 (de) 1990-10-24
HU202507B (en) 1991-03-28
IL90337A0 (en) 1989-12-15
KR910006864B1 (ko) 1991-09-09
PT90622A (pt) 1989-11-30
DE68902358T2 (de) 1992-12-10
ATE79114T1 (de) 1992-08-15
YU105989A (en) 1990-08-31
MX16158A (es) 1993-06-01
PL279613A1 (en) 1989-11-27
NO172389C (no) 1993-07-14
JPH0678331B2 (ja) 1994-10-05
ZA893862B (en) 1991-01-30
CA1328871C (en) 1994-04-26
AU3509889A (en) 1989-11-30
NZ229234A (en) 1990-09-26
PL154875B1 (en) 1991-09-30
IE891667L (en) 1989-11-24
EP0343893B1 (en) 1992-08-05
AU601905B2 (en) 1990-09-20
FI892498A0 (fi) 1989-05-23
GR3005844T3 (en:Method) 1993-06-07
MX173140B (es) 1994-02-02
YU47019B (sh) 1994-11-15
HUT51606A (en) 1990-05-28
CN1023700C (zh) 1994-02-09
FI892498A7 (fi) 1989-11-25
DK249389D0 (da) 1989-05-23
CN1037898A (zh) 1989-12-13
NO172389B (no) 1993-04-05
NO892059D0 (no) 1989-05-23
MY106035A (en) 1995-03-31
EP0343893A1 (en) 1989-11-29

Similar Documents

Publication Publication Date Title
ES2043012T3 (es) Derivados de carboxamidas aromaticas y heterociclicas como agentes antineoplasticos.
NL970024I1 (nl) Anti-tumor middelen.
MC1992A1 (fr) Derives de fluorocytidine
FI893618A0 (fi) Aminometyloxooxazolidinylarylbensen -derivat anvaendbara saosom antibakteriella medel.
FI863189A7 (fi) Luun morfogeneettisiä aineita.
FI895953A7 (fi) Kasvainvastaisia aineita
FI882742L (fi) Vaordande medel och dessa innehaollande kompositioner.
DE3875692D1 (de) Muster-verabreichungsanordnung.
FI943019A7 (fi) Terapeuttisia aineita
NO900790L (no) Melatoninanaloger.
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
FI884067L (fi) Avfaergningsmedel foer avfallspapper.
FI895447A7 (fi) Substituoidut terapeuttisina aineina käytettävät adeniinijohdannaiset
NO884833D0 (no) Maalrettede former av metyltritio-anti-tumormidler.
DE3875934D1 (de) Antiarrythmische derivate 1.
MC1970A1 (fr) Derives acyles
FI884070L (fi) Rytmstoerningar foerhindrande medel.
FI891467L (fi) Sjaelvstabiliserade dipeptidsoetningsmedel.
FI884107A0 (fi) Saosom antibakteriella medel anvaendbara 4-oxo-3-kinolin-karboxyl-syror och deras framstaellning.
MC2000A1 (fr) Derives acyles
FI883513A0 (fi) Anordning och foerfaranden foer att foerminska pannstensbildning i samband med kokprocesser foer cellulosa.
ATE57526T1 (de) P-acylaminobenzamide.
IT1222867B (it) Ftalazino derivati ad attivita' farmaceutica
FI881893L (fi) Garvmedel.
FI950101A0 (fi) 4-oksa-1-atsabisyklo 3,2,0 -7heptanoni-johdannaiset kasvainten vastaisina aineina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 343893

Country of ref document: ES